Clal Biotechnology | CBI - Ordinary Share Capital


Clal Biotechnology reported ILS1.61M in Ordinary Share Capital for its fiscal quarter ending in December of 2022.





Ordinary Share Capital Change Date
Arca Biopharma USD 48.72M 338K Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
Bio Path USD 9.24M 934K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 2K Dec/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
RedHill Biopharma USD 50.92B 17.62B Dec/2025
TherapeuticsMD USD 11K 0 Sep/2023